TickerFactsScreenerDevelopers

Foghorn Therapeutics Inc. (FHTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$46.34M2020: -$31.29M2021: -$50.25M2022: $193.61M2023: -$118.11M2024: -$100.41M2025: -$86.10M-$86.10M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$86.10M+14.2%
2024-$100.41M+15.0%
2023-$118.11M-161.0%
2022$193.61M+485.3%
2021-$50.25M-60.6%
2020-$31.29M+32.5%
2019-$46.34M—